sales history since ipo
play

SALES HISTORY SINCE IPO 35,000,000 2019 19-20 20 in su summa - PowerPoint PPT Presentation

SALES HISTORY SINCE IPO 35,000,000 2019 19-20 20 in su summa mary 30,000,000 15 years as a public company 25,000,000 Acquisition of Tristel Italia 20,000,000 Launch of Cache surface portfolio 15,000,000


  1. SALES HISTORY – SINCE IPO £35,000,000 2019 19-20 20 in su summa mary £30,000,000 15 years as a public company • £25,000,000 Acquisition of Tristel Italia • £20,000,000 • Launch of Cache surface portfolio £15,000,000 • Impact of Covid-19 £10,000,000 • 21% y-o-y sales growth in 2020 £5,000,000 • 17% CAGR since IPO £- 1 1 1

  2. SALES HISTORY – BY GEOGRAPHY 2019 19-20 20 in su summa mary £35,000,000 • UK sales growth 7% £30,000,000 • International sales growth 32% £25,000,000 International sales benefit from • £20,000,000 Tristel Italia contribution – acquired July 19 £15,000,000 • International sales now represent £10,000,000 60% of all revenue £5,000,000 £- 2015-16 2016-17 2017-18 2018-19 2019-20 UK sales International sales 2 2

  3. SALES HISTORY – BY PRODUCT CATEGORY £35,000,000 2019 19-20 20 in su summa mary 12% Tristel medical device sales £30,000,000 • growth £25,000,000 • 139% Cache surface sales growth £20,000,000 Est stima mated d Covi ovid-19 impa pact £15,000,000 £500k reduction in Tristel medical • device sales £10,000,000 £2m increase in Cache surface • £5,000,000 sales £- 2015-16 2016-17 2017-18 2018-19 2019-20 Other Cache Surfaces Tristel Medical Devices 3

  4. SECOND HALF SALES – COVID IMPACT Secon ond d half lf 2019 19-20 20 March: Hospitals build their stock of • £3,000,000 all infection prevention products. £2,500,000 • April: Out-patient departments close to all but Covid-19 patients. £2,000,000 Reduced Tristel sales, but Cache sales hit an all time high. £1,500,000 • May: Australasia, Asia & Europe £1,000,000 outpatient departments prepare to re-open. £500,000 June: UK out-patient departments • prepare to re-open. £- Jan-20 Feb-20 Mar-20 Apr-20 May-20 Jun-20 Tristel Medical Devices Cache Surfaces Other 4

  5. COVID IMPACT - PRODUCTION Bulk Solution Manufacture 2019-20 Februar Fe ruary & Ma Marc rch 202 020 • Senior management team 250,000L prepares a Covid-19 response plan April il & May May 202 020 200,000L • 100% increase in bulk solution 150,000L manufacture • 100% increase in out-sourced 100,000L sachet filling output 50,000L 100% increase in production • personnel 0L The implementation of a fast • Jan-20 Feb-20 Mar-20 Apr-20 May-20 Jun-20 response plan allowed demand to be met. 5

Recommend


More recommend